Autosomal recessive combined immunodeficiency due to complete IL6ST deficiency
aw-toh-soh-muhl rih-ses-iv kuhm-bahynd ih-myoo-noh-dih-fish-uhn-see due to kom-pleet IL6ST dih-fish-uhn-see
Also known as: IL6ST deficiency, gp130 deficiency
At a Glance
What is Autosomal recessive combined immunodeficiency due to complete IL6ST deficiency?
Autosomal recessive combined immunodeficiency due to complete IL6ST deficiency is a rare genetic disorder that affects the immune system. It is caused by mutations in the IL6ST gene, which is crucial for immune signaling. This condition leads to a weakened immune system, making individuals more susceptible to infections. Symptoms often begin in infancy and can include frequent infections, poor growth, and developmental delays. Early symptoms may be mild, but without treatment, the condition can progress to severe infections and complications. Early diagnosis is critical to manage the condition and prevent life-threatening infections. The disorder can significantly impact family life, requiring constant medical care and attention. Prognosis varies, but with early intervention, some individuals can manage the condition with treatments like bone marrow transplants. Daily life for affected individuals often involves regular medical check-ups and preventive measures to avoid infections. Families may need to adapt their lifestyles to accommodate the medical needs of the affected individual. Support from healthcare providers and patient communities can be invaluable. Genetic counseling is recommended for families to understand the inheritance pattern and risks for future children.
Medical Definition
Autosomal recessive combined immunodeficiency due to complete IL6ST deficiency is characterized by the absence of functional gp130, a signal transducer for multiple cytokines. Pathologically, this results in impaired immune responses, particularly affecting T and B lymphocyte function. Histological findings may include lymphoid hypoplasia and reduced cellularity in lymphoid tissues. It is classified under primary immunodeficiency disorders, specifically affecting cytokine signaling pathways. Epidemiologically, it is extremely rare, with few documented cases worldwide. The disease course is progressive, with increasing susceptibility to infections and potential for severe complications without intervention.
Autosomal recessive combined immunodeficiency due to complete IL6ST deficiency Symptoms
Symptoms vary in severity between individuals. Early diagnosis and management can significantly improve outcomes.
Very Common
Recurrent infections manifest as frequent episodes of bacterial, viral, or fungal infections due to the impaired immune response. This occurs because the IL6ST deficiency disrupts cytokine signaling pathways essential for immune cell function. Over time, these infections can become more severe and resistant to standard treatments. Daily life is significantly impacted as patients may require frequent medical interventions and hospitalizations, and prophylactic antibiotics or immunoglobulin therapy can be used to manage this symptom.
Failure to thrive is observed as poor weight gain and growth in infants and children, often due to chronic illness and malabsorption. The biological mechanism involves the body's inability to effectively utilize nutrients due to ongoing infections and inflammation. Without intervention, this can lead to developmental delays and stunted growth. Nutritional support and addressing underlying infections are crucial to improve growth outcomes.
Chronic diarrhea presents as persistent loose stools, which can lead to dehydration and electrolyte imbalances. It is caused by gastrointestinal infections and inflammation due to the compromised immune system. If left untreated, it can result in significant weight loss and nutritional deficiencies. Management includes rehydration, dietary modifications, and treatment of underlying infections to alleviate symptoms.
Common
Skin rashes appear as red, itchy, and inflamed patches on the skin, often due to allergic reactions or infections. The underlying cause is the immune system's inability to regulate inflammatory responses properly. These rashes can persist or recur over time, causing discomfort and potential skin damage. Topical treatments and antihistamines can help manage the symptoms and improve skin condition.
Lymphadenopathy is characterized by swollen lymph nodes, which can be tender or painless. This occurs due to the accumulation of immune cells in response to chronic infections or inflammation. Over time, persistent lymphadenopathy can indicate ongoing immune dysregulation. Regular monitoring and addressing the underlying cause are essential for managing this symptom.
Hepatosplenomegaly is the enlargement of the liver and spleen, often detected during physical examination. It results from the accumulation of immune cells and increased workload of these organs due to chronic infections. If progressive, it can lead to abdominal discomfort and impaired organ function. Management involves treating the underlying infections and monitoring organ size and function.
Less Common
Autoimmune manifestations can include a variety of symptoms such as joint pain, skin changes, or organ-specific issues. These occur when the immune system mistakenly attacks the body's own tissues due to dysregulated immune responses. Over time, these manifestations can lead to chronic pain or organ damage. Immunosuppressive therapies may be required to manage these symptoms effectively.
Growth hormone deficiency is observed as reduced growth velocity and short stature in affected individuals. It is caused by the impaired function of the pituitary gland, potentially due to chronic inflammation or infections. Without treatment, this can lead to significant height deficits and potential psychosocial issues. Growth hormone replacement therapy can be administered to promote normal growth and development.
What Causes Autosomal recessive combined immunodeficiency due to complete IL6ST deficiency?
Autosomal recessive combined immunodeficiency due to complete IL6ST deficiency is caused by mutations in the IL6ST gene, located on chromosome 5q11.2. The IL6ST gene encodes the gp130 protein, which is a signal transducer for the interleukin-6 (IL-6) cytokine family. Normally, gp130 forms a complex with other receptor subunits to mediate signaling pathways critical for immune responses and hematopoiesis. Mutations in IL6ST can lead to structural changes that impair gp130's ability to bind with its receptor partners, disrupting downstream signaling. This disruption results in impaired activation of the JAK/STAT signaling pathway, a critical pathway for immune cell function. Consequently, there is a failure in the proper development and function of immune cells, leading to immunodeficiency. The lack of functional immune signaling can cause neuroinflammation due to an inability to regulate immune responses effectively. This neuroinflammation can contribute to the degeneration of white matter and other neural structures. Symptoms appear in a specific pattern due to the critical role of the IL-6 signaling pathway in various tissues, including the immune system and central nervous system. The severity of the disease can vary between patients due to differences in the specific mutations within the IL6ST gene and potential compensatory mechanisms in other signaling pathways.
How is Autosomal recessive combined immunodeficiency due to complete IL6ST deficiency Diagnosed?
Typical age of diagnosis: Diagnosis typically occurs in early childhood, often within the first year of life, when recurrent infections and failure to thrive prompt further investigation. The condition is suspected based on clinical presentation and family history, especially in consanguineous families.
Clinicians look for signs of recurrent infections, failure to thrive, and chronic diarrhea. A detailed family history is crucial, particularly noting consanguinity and siblings with similar symptoms. Physical examination may reveal lymphadenopathy, hepatosplenomegaly, and eczema. This step helps to rule out other common causes of immunodeficiency and guides further diagnostic testing.
Chest X-rays or CT scans are typically used to assess for lung abnormalities such as bronchiectasis. Imaging may reveal lymphoid tissue hypoplasia or absence, which supports the diagnosis of immunodeficiency. These findings help confirm the diagnosis by excluding other causes of recurrent infections, such as cystic fibrosis. Imaging also assists in evaluating the extent of organ involvement and guides further management.
Complete blood count and immunoglobulin levels are ordered to assess immune function. Low levels of immunoglobulins and lymphocyte subsets are indicative of immunodeficiency. Abnormal results, such as low T-cell and B-cell counts, guide the clinician towards considering genetic testing. These tests are critical in differentiating between various types of immunodeficiencies and planning appropriate treatment.
Genetic testing focuses on sequencing the IL6ST gene to identify mutations. Typically, nonsense or frameshift mutations are found, leading to complete deficiency. Confirmation of these mutations establishes the diagnosis of autosomal recessive combined immunodeficiency due to IL6ST deficiency. Genetic results also provide essential information for family counseling and assessing the risk of recurrence in future pregnancies.
Autosomal recessive combined immunodeficiency due to complete IL6ST deficiency Treatment Options
This therapy involves the administration of intravenous or subcutaneous immunoglobulins. It works by providing passive immunity to patients with antibody deficiencies. Specific products used include IVIG and SCIG, which have shown efficacy in reducing infection rates. Clinical evidence supports its use in improving quality of life and reducing hospitalizations. Limitations include potential side effects such as allergic reactions and the need for regular infusions.
Techniques such as chest physiotherapy and breathing exercises are employed. The goal is to improve lung function and prevent respiratory complications. Sessions are typically conducted several times a week, lasting 30-60 minutes each. Measurable outcomes include improved pulmonary function tests and reduced respiratory infections. Long-term benefits include enhanced respiratory health and quality of life.
Indicated for severe cases where pharmacological treatment is insufficient. The procedure involves the transplantation of healthy stem cells to reconstitute the immune system. Expected benefits include potential cure and restoration of normal immune function. Surgical risks include graft-versus-host disease and infection. Post-operative care requires immunosuppressive therapy and regular monitoring for complications.
The care team includes immunologists, nutritionists, and social workers. Interventions focus on infection prevention, nutritional support, and psychosocial care. Strategies include regular vaccinations, dietary planning, and counseling services. Family education is provided on managing the condition and recognizing early signs of complications. Long-term monitoring involves regular follow-ups and adjustments to care plans as needed.
When to See a Doctor for Autosomal recessive combined immunodeficiency due to complete IL6ST deficiency
- Severe respiratory distress — this is an emergency as it can indicate a life-threatening infection or complication.
- High fever unresponsive to medication — this could signal a serious infection requiring immediate medical attention.
- Sudden, unexplained bleeding or bruising — this may indicate a critical issue with blood clotting or platelet function.
- Frequent infections — this is significant as it may suggest an underlying immunodeficiency, requiring evaluation by a specialist.
- Chronic diarrhea — this can lead to dehydration and malnutrition, necessitating medical assessment.
- Persistent fatigue — this could be a sign of systemic involvement and should be discussed with a healthcare provider.
- Mild skin rashes — monitor for changes or worsening, and consult a doctor if it persists.
- Occasional mild cough — monitor for persistence or worsening, and ensure it does not develop into a more severe respiratory issue.
Autosomal recessive combined immunodeficiency due to complete IL6ST deficiency — Frequently Asked Questions
Is this condition hereditary?
Autosomal recessive combined immunodeficiency due to complete IL6ST deficiency is inherited in an autosomal recessive pattern. This means both parents must be carriers for a child to be affected, with a 25% chance for each child to inherit the condition. De novo mutations are not typically involved in this condition. Carrier status can be identified through genetic testing, which is important for family planning. Genetic counseling is recommended to understand the risks and implications for family members.
What is the life expectancy for someone with this condition?
Life expectancy varies greatly depending on the age of onset and severity of the condition. Early diagnosis and treatment can significantly improve outcomes, while delayed treatment may worsen prognosis. Mortality is often due to severe infections or complications related to immunodeficiency. With appropriate medical management, including potential bone marrow transplantation, survival rates can improve. Realistic expectations should include ongoing medical care and monitoring.
How is this condition diagnosed and how long does diagnosis take?
Diagnosis typically involves a combination of clinical evaluation, immunological testing, and genetic sequencing. The time from first symptoms to diagnosis can vary, often taking months to years due to the rarity of the condition. Specialists such as immunologists and geneticists are usually consulted. Delays in diagnosis are common due to non-specific symptoms and lack of awareness. Genetic testing confirming IL6ST deficiency ultimately confirms the diagnosis.
Are there any new treatments or clinical trials available?
Research is ongoing, with gene therapy being a promising area of study for this condition. Novel approaches aim to correct the underlying genetic defect or enhance immune function. Clinical trials can be found on ClinicalTrials.gov by searching for IL6ST deficiency or related terms. It is important to discuss potential trial participation with your doctor. New treatments may take several years to become widely available.
How does this condition affect daily life and activities?
This condition can significantly impact mobility and self-care due to frequent infections and hospitalizations. Educational challenges may arise from missed school and cognitive effects of chronic illness. Social and emotional challenges include isolation and anxiety related to health. Family burden is substantial, often requiring adjustments in daily routines and caregiving roles. Supports such as home healthcare, educational accommodations, and counseling can be beneficial.
Learn More
Support & Resources
References
Content generated with support from peer-reviewed literature via PubMed.
- 1.Rapid identification of primary atopic disorders (PAD) by a clinical landmark-guided, upfront use of genomic sequencing.
Niehues T, von Hardenberg S, Velleuer E · Allergol Select · 2024 · PMID: 39381601
- 2.Inherited human ZNF341 deficiency.
Béziat V, Fieschi C, Momenilandi M et al. · Curr Opin Immunol · 2023 · PMID: 37080116
This content is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.Last reviewed: 2026-05-17